Section 5-19.2-3 - Collaborative pharmacy practice(a) A pharmacist may engage in collaborative pharmacy practice pursuant to a collaborative practice agreement in accordance with provisions of this chapter or other applicable sections of the regulations. Any pharmacist or physician desiring to engage in collaborate pharmacy practice shall execute a collaborative practice agreement in accordance with regulations promulgated by the department. Each collaborative practice agreement shall set forth at least the following: (1) Site and setting where the collaborative practice is to take place;(2) Informed consent procedures;(3) Qualifications of participating pharmacists and physicians;(4) The role of any employed healthcare professional with prescriptive privileges participating in the collaborative practice;(5) Scope of conditions or diseases to be managed;(7) Risk management activities; and(8) Outcomes measurements. Each collaborative practice agreement shall be subject to review and renewal on a biennial basis.(b) Any pharmacist or physician who deviates from, or practices in a manner inconsistent with, the terms of a collaborative practice agreement shall be in violation of this chapter; such shall constitute grounds for disciplinary action pursuant to this chapter. There shall be no civil liability on the part of, or cause of action of any nature against, a physician or a physician's agents or employees for participation in collaborative pharmacy practice as the result of negligence or fault on the part of the pharmacist participating in such collaborative practice agreement.R.I. Gen. Laws § 5-19.2-3
Amended by 2016 Pub. Laws, ch. 72,§ 1, eff. 6/13/2016.Amended by 2016 Pub. Laws, ch. 64,§ 1, eff. 6/13/2016. P.L. 2001, ch. 68, § 1; P.L. 2009, ch. 310, § 26.